PhaseBio Pharmaceuticals (PHAS) SEC Filings & 10K Form

Recent PhaseBio Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/12/2024
3:34 PM
PhaseBio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2023
3:55 PM
PhaseBio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
6:17 AM
PhaseBio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
7:52 AM
PhaseBio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
11:31 AM
PhaseBio Pharmaceuticals (Filer)
Form NT 10-Q
08/25/2023
11:34 AM
PhaseBio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
3:21 PM
PhaseBio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
7:08 AM
PhaseBio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PHAS) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners